Cancer survival in Germany and the United States at the beginning of the 21st century: An up-to-date comparison by period analysis
| Autor: | Hartwig Ziegler, Hermann Brenner, Adam Gondos, Volker Arndt, Bernd Holleczek, Christa Stegmaier |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Adult
Male Oncology Cancer Research medicine.medical_specialty Lung Neoplasms Adolescent Breast Neoplasms Prostate cancer Breast cancer Germany Neoplasms Internal medicine medicine Humans Survivors Stomach cancer Survival analysis Aged Neoplasm Staging Relative survival business.industry Incidence (epidemiology) Age Factors Prostatic Neoplasms Cancer Middle Aged medicine.disease Survival Analysis United States Cancer registry Survival Rate Colonic Neoplasms Regression Analysis Female business Follow-Up Studies |
| Zdroj: | International Journal of Cancer. 121:395-400 |
| ISSN: | 1097-0215 0020-7136 |
| DOI: | 10.1002/ijc.22683 |
| Popis: | Transatlantic cancer survival comparisons are scarce and involve mostly aggregate European data from the late 1980s. We compare the levels of cancer patient survival achieved in Germany and the United States (US) by the beginning of the 21st century, using data from the Cancer Registry of Saarland/Germany and the SEER Program of the US. Age-adjusted 5- and 10-year relative survival for 23 common forms of cancer derived by period analysis for the 2000-2002 period were calculated, with additional detailed age- and stage-specific analyses for cancers with the highest incidence. Among the 23 cancer sites, 5 (10) year relative survival was significantly higher for 1 (2) and 8 (5) cancers in Germany and the US, respectively. In Germany, survival was significantly higher for patients with stomach cancer, whereas survival was higher in the US for patients with breast, cervical, prostate, colorectal and oral cavity cancer. Among the most common cancers, age-specific survival differences were particularly pronounced for older patients with breast, colorectal and prostate cancer. Survival advantages of breast cancer patients in the US were mainly due to more favorable stage distributions. This comprehensive survival comparison between Germany and the US suggests that although survival was similar for the majority of the compared cancer sites, long-term prognosis of patients continues to be better in the US for many of the most common forms of cancer. Among these, differences between patients with breast and prostate cancer are probably due to more intensive screening activities. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text